You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acquired Resistance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Antibiotic Resistance and Incidence of Sepsis in Community

Not yet recruiting
  • Community-acquired Pneumonia
  • +2 more
    • (no location specified)
    Nov 3, 2022

    Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

    Not yet recruiting
    • Metastatic Extracranial Malignant Solid Neoplasm
    • +3 more
    • Intestinal Low Dose Radiotherapy-1Gy
    • +3 more
    • Shantou, Guangdong, China
      Cancer Hospital, Shantou University Medical College
    Oct 7, 2023

    Studying Pathways of Resistance in KRAS-driven Cancers

    Not yet recruiting
    • KRAS P.G12C
    • FoundationOne® Liquid CDx
    • (no location specified)
    Mar 9, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    Community-acquired Pneumonia Trial in Moscow (Interferon-Gamma)

    Completed
    • Community-acquired Pneumonia
    • Moscow, Russian Federation
      City Clinical Hospital named after M.E. Zhadkevich Moscow City H
    May 24, 2022

    Acquired Endocrine Resistance in Metastatic Breast Cancer: A

    Recruiting
    • Metastatic Breast Cancer
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      May 4, 2022

      Drug Resistance in Immune Checkpoint Inhibitors of Non-small

      Recruiting
      • Non-Small Cell Lung Cancer
      • Anti-PD-1/PD-L1 monoclonal antibody
      • Shanghai, Shanghai, China
        Xiaomin Niu
      Jul 24, 2021

      Non-Small Cell Lung Carcinoma Trial in Duarte, Stanford, Nashville (drug, biological, other)

      Terminated
      • Non-Small Cell Lung Carcinoma
      • Duarte, California
      • +2 more
      Apr 6, 2022

      Metastatic Colorectal Cancer Trial in Denmark, Germany, Spain (FOLFIRI Protocol, SCO-101)

      Recruiting
      • Metastatic Colorectal Cancer
      • Aalborg, Denmark
      • +11 more
      Feb 28, 2022

      Phenotypic and Genotypic Variations of Enterococcus Spp

      Not yet recruiting
      • Isolation of Enterococci From Samples
      • +5 more
      • Culture
      • +7 more
      • (no location specified)
      Mar 1, 2023

      HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)

      Completed
      • HIV/AIDS
      • Intensified monitoring
      • Standard of care monitoring
      • Elandsdoorn, Limpopo, South Africa
        Ndlovu Medical Centre
      May 10, 2022

      Increasing Insulin Resistance asPredictor of Impending

      Not yet recruiting
      • Acquired ICU Bacteremia
        • Kfar Saba, Israel
          Meir medical center Kfar Saba
        Sep 9, 2021

        EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

        Active, not recruiting
        • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
        • Großhansdorf, Germany
        • +17 more
        Jan 12, 2023

        Community Acquired Pneumonia in Hospital in More Severe

        Recruiting
        • Pneumonia
        • +2 more
          • Berlin, Germany
          • +7 more
          Jan 9, 2023

          Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

          Enrolling by invitation
          • Ventilator-associated Pneumonia
          • Hospital-acquired Pneumonia
          • Observational
          • Dallas, Texas
            Methodist Dallas Medical Center
          Dec 9, 2021

          HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))

          Not yet recruiting
          • HIV/AIDS
          • Intensive Adherence Counselling (IAC)
          • Masaka, Uganda
            Kalisizo Hospital
          Aug 22, 2022

          Human Immunodeficiency Virus, Metabolic Syndrome Trial run by the NIAID (Intermittent fasting, Standard of Care)

          Terminated
          • Human Immunodeficiency Virus
          • Metabolic Syndrome
          • Intermittent fasting
          • Standard of Care
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 21, 2021

          Lung Tumors, EGFR Gene Mutations Trial in Hwasun (Osimertinib)

          Completed
          • Lung Neoplasms
          • EGFR Gene Mutations
          • Hwasun, Jeonnam, Korea, Republic of
            Chonnam National University Hwasun Hospital
          Aug 1, 2021

          Bacteremia, Sepsis, Hospital Acquired Condition Trial in Brisbane, Paris

          Completed
          • Bacteremia
          • +3 more
            • Brisbane, Queensland, Australia
            • +1 more
            Sep 8, 2021

            Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

            Recruiting
            • Bronchial Neoplasms
            • Cologne, Germany
            • +6 more
            Nov 2, 2022

            NSCLC Trial in Worldwide (Tepotinib, Gefitinib, Pemetrexed)

            Completed
            Has Results
            • Non-small Cell Lung Cancer
            • Beijing, China
            • +43 more
            Oct 13, 2022

            Acquired Clinical Resistance to Crizotinib in Non-small Cell

            Completed
            • Lung Cancer
            • obtain tissue specimens
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Jan 6, 2021

            Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

            Recruiting
            • Lung Neoplasms
            • +23 more
            • La Jolla, California
            • +35 more
            Oct 6, 2022